| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-06 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |